Blue Earth Therapeutics partners with UCL for prostate cancer therapy trial

Blue Earth Therapeutics has entered a clinical research partnership with University College London in the UK to progress the clinical development of an Alpha-labelled Radioligand Therapy (RLT) for prostate cancer.